Cidara Therapeutics Provides Corporate Update and Reports
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics...
Source: globenewswire.com
Page 48 - Brian Ritchie News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Brian Ritchie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Brian Ritchie Today - Breaking & Trending Today
Zogenix, Inc: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
Total revenue of $26.6 million in the fourth quarter and $81.7 million for the full yearFINTEPLA® net product sales of $23.5 million in the fourth quarter and $74.7 million for the full year Announced
Source: finanznachrichten.de
TRACON to Report Fourth Quarter and Full Year 2021
SAN DIEGO, March 04, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the...
Source: globenewswire.com
Mundipharma and Cidara Therapeutics, Inc.: Rezafungin Awarded Promising Innovation Medicine (PIM) Designation by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Invasive Candidiasis
For Trade and Medical Media Only Rezafungin is a next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis
Source: finanznachrichten.de
iCAD (ICAD) Q4 2021 Earnings Call Transcript
ICAD earnings call for the period ending December 31, 2021.
Source: fool.com